Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Mercedes Santoro

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Chemmedchem|September 29, 2011
Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirineStefano Alcaro, Claudia Alteri, Anna Artese, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2020
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and ItalyCathia Soulie, Maria Mercedes Santoro, Alexandre Storto, et al.
BMJ Open|February 10, 2024
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitorsTommaso Clemente, Laura Galli, Riccardo Lolatto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 9, 2018
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatmentDaniele Armenia, Mauro Zaccarelli, Vanni Borghi, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2021
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settingsEzechiel Ngoufack Jagni Semengue, Daniele Armenia, Seth Inzaule, et al.
Open Forum Infectious Diseases|November 26, 2020
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO RegistryLaura Galli, Maria Rita Parisi, Andrea Poli, et al.
International Journal of Antimicrobial Agents|November 17, 2025
Impact of DNA-stored mutations on virological response in virologically suppressed PWH in the switch to modern regimensFrancesca Lombardi, Elio Gentilini Cacciola, Federica Carli, et al.
Microbes and Infection|February 2, 2025
The transactivation of human endogenous retroviruses is associated with HIV-1 reservoir, lymphocyte activation and low CD4 count in virologically suppressed PLWHVita Petrone, Rossana Scutari, Vincenzo Malagnino, et al.
BMJ Open|October 10, 2023
Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysisAude Christelle Ka'e, Aubin Nanfack, Maria-Mercedes Santoro, et al.
Journal of Clinical Microbiology|July 14, 2017
Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 StrainsLavinia Fabeni, Giulia Berno, Joseph Fokam, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Chemmedchem|September 29, 2011
Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirineStefano Alcaro, Claudia Alteri, Anna Artese, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2020
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and ItalyCathia Soulie, Maria Mercedes Santoro, Alexandre Storto, et al.
BMJ Open|February 10, 2024
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitorsTommaso Clemente, Laura Galli, Riccardo Lolatto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 9, 2018
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatmentDaniele Armenia, Mauro Zaccarelli, Vanni Borghi, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2021
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settingsEzechiel Ngoufack Jagni Semengue, Daniele Armenia, Seth Inzaule, et al.
Open Forum Infectious Diseases|November 26, 2020
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO RegistryLaura Galli, Maria Rita Parisi, Andrea Poli, et al.
International Journal of Antimicrobial Agents|November 17, 2025
Impact of DNA-stored mutations on virological response in virologically suppressed PWH in the switch to modern regimensFrancesca Lombardi, Elio Gentilini Cacciola, Federica Carli, et al.
Microbes and Infection|February 2, 2025
The transactivation of human endogenous retroviruses is associated with HIV-1 reservoir, lymphocyte activation and low CD4 count in virologically suppressed PLWHVita Petrone, Rossana Scutari, Vincenzo Malagnino, et al.
BMJ Open|October 10, 2023
Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysisAude Christelle Ka'e, Aubin Nanfack, Maria-Mercedes Santoro, et al.
Journal of Clinical Microbiology|July 14, 2017
Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 StrainsLavinia Fabeni, Giulia Berno, Joseph Fokam, et al.
Pageof 14